574 Results for "

PCAF bromodomain binder

" in MedChemExpress (MCE) Product Catalog:
Products (574)

574 Results for "PCAF bromodomain binder" in MCE Product Catalog:

310
310 Publications Verification
Cat. No.: HY-13030
CAS No.: 1268524-70-4
Purity:  99.90%
Synonyms: JQ1
(+)-JQ-1 (JQ1), a chemical probe, is a potent, specific, CNS-penetrant and reversible BET bromodomain inhibitor, with IC50s of 77 and 33 nM for the first and second bromodomain (BRD4(1/2)) . (+)-JQ-1 also activates autophagy .
loading...
    loading...
41
41 Cited Publications
Cat. No.: HY-15743
CAS No.: 202590-98-5
Purity:  99.75%
Synonyms: OTX-015; MK-8628
Research Areas:  

Cancer

Birabresib (OTX-015) is a potent bromodomain (BRD2/3/4) inhibitor with IC50s ranging from 92 to 112 nM.
loading...
    loading...
30
30 Cited Publications
Cat. No.: HY-13235
CAS No.: 1300031-49-5
Purity:  99.81%
Synonyms: GSK1210151A
Research Areas:  

Cancer

I-BET151 (GSK1210151A) is a BET bromodomain inhibitor which inhibits BRD4, BRD2, and BRD3 with pIC50 of 6.1, 6.3, and 6.6, respectively .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-13032
CAS No.: 1260907-17-2
Purity:  99.94%
Synonyms: I-BET762; GSK525762; GSK525762A
Research Areas:  

Cancer

Molibresib (I-BET762; GSK525762) is a BET bromodomain inhibitor with IC50 of 32.5-42.5 nM.
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-15826
CAS No.: 1613695-14-9
Purity:  99.60%
SGC-CBP30, a chemical probe, is a potent and highly selective CBP/p300 bromodomain (Kds of 21 nM and 32 nM for CBP and p300, respectively) inhibitor, displaying 40-fold selectivity over the first bromodomain of BRD4 [BRD4(1)] bound. SGC-CBP30 strongly reduces secretion of IL-17A in Th17 cells and has anti-inflammatory effects .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-N2020
CAS No.: 16611-84-0
Synonyms: Hydroginkgolic acid; Ginkgolic Acid C15:0
Anacardic Acid, extracted from cashew nut shell liquid, is a histone acetyltransferase inhibitor, inhibits HAT activity of p300 and PCAF, with IC50s of ∼8.5 μM and ∼5 μM, respectively.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-100015
CAS No.: 1445993-26-9
Purity:  99.29%
Synonyms: ABBV-075
Research Areas:  

Cancer

Mivebresib (ABBV-075) is a potent and orally active bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a Ki of 1.5 nM .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-15887
CAS No.: 1243583-85-8
Purity:  99.24%
Synonyms: Tip60 HAT inhibitor
MG149 (Tip60 HAT inhibitor) is a selective and potent Tip60 inhibitor with IC50 of 74 uM, similar potentcy for MOF (IC50 = 47 uM); little potent for PCAF and p300 (IC50 >200 uM). MG 149 inhibits KAT8 and blocks PINK1 kinase activity. MG149 inhibits the phosphorylation of Parkin and ubiquitin, thereby suppressing the initiation of PINK1-dependent mitophagy. MG 149 can reverse chronic restraint stress (CRS) induced hypertension and related molecular changes. MG 149 commonly used in research on diseases such as hypertension and Parkinson's disease .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-100482
CAS No.: 1884712-47-3
Purity:  99.91%
CPI-637 is a selective and potent CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 μM, 0.051 μM and 11.0 μM for CBP, EP300 and BRD4 BD-1, respectively, and an EC50 of 0.3 μM for CBP .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-111784
CAS No.: 2222941-37-7
Purity:  99.94%
Synonyms: CCS1477
Inobrodib (CCS1477) is an orally active, potent, and selective inhibitor of the p300/CBP bromodomain. Inobrodib binds to p300 and CBP with Kd values of 1.3 and 1.7 nM, respectively, and with 170/130-fold selectivity compared with BRD4 with a Kd of 222 nM. CCS1477 inhibits cell proliferation in prostate cancer cell lines and decreases androgen receptor (AR)- and C-MYC-regulated gene expression .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-18975
CAS No.: 1714146-59-4
Research Areas:  

Inflammation/Immunology Cancer

I-BRD9 is a selective cellular chemical probe of bromodomain-containing protein 9 (BRD9) with pIC50 value of 7.3 μM. I-BRD9 has high selectivity for bromodomain and extra terminal domain (BET) family and highly homologous bromodomain-containing protein 7 (BRD7). I-BRD9 can be used to identify genes regulated by BRD9 in Kasumi-1 cells involved in oncology and immune response pathways .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-16293
CAS No.: 497871-47-3
Synonyms: PM01183; LY-01017
Research Areas:  

Cancer

Lurbinectedin (PM01183) is a DNA minor groove covalent binder with potent anti-tumour activity; inhibits RMG1 and RMG2 cell growth with IC50 values of 1.25 and 1.16 nM, respectively.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-16652
CAS No.: 1044870-39-4
Synonyms: RVX-208; RVX000222
Research Areas:  

Cancer

Apabetalone (RVX-208) is an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. The IC50s are 87 μM and 0.51 μM for BD1 and BD2, respectively .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-78695
CAS No.: 202592-23-2
JQ-1 carboxylic acid, a (+)-JQ-1 (HY-13030) derivative, is a potent BET bromodomain inhibitor. JQ-1 carboxylic acid can be used to synthesize PROTAC, which can target the degradation of BRD4.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-110127
CAS No.: 1450644-28-6
Purity:  95.36%
Research Areas:  

Cancer

NU9056 is a potent and selective Tip60 (KAT5) histone acetyltransferase inhibitor with an of 2 µM. NU9056 shows >16-fold selectivity for Tip60 over PCAF, p300 and GCN5. NU9056 induces apoptosis of prostate cancer cells .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-100653
CAS No.: 1869912-39-9
Purity:  99.20%
Research Areas:  

Cancer

AZD5153 is a bivalent, selective, and orally active BET/BRD4 bromodomain inhibitor with an IC50 of value of 5 nM for full-length BRD4 (FL-BRD4). AZD5153 ligates two bromodomains in BRD4 simultaneously. AZD5153 can be used for the study of cancer, such as acute myeloid leukemia, multiple myeloma, and diffuse large B-cell lymphoma .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15846
CAS No.: 1446144-04-2
Purity:  98.98%
Research Areas:  

Cancer

CPI-203 is a novel potent, selective and cell permeable inhibitor of BET bromodomain, with an IC50 value of appr 37 nM (BRD4 α-screen assay).
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-N1428C
CAS No.: 3522-50-7
Synonyms: Iron(III) citrate; Zerenex
Ferric citrate (Iron(III) citrate), an orally active iron supplement, is an efficacious phosphate binder. Ferric citratee can be used for iron deficiency anemia and chronic kidney disease (CKD) research .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-100653A
CAS No.: 1869912-40-2
Purity:  99.80%
Research Areas:  

Cancer

AZD5153 6-Hydroxy-2-naphthoic acid is the 6-Hydroxy-2-naphthoic acid of AZD5153. AZD5153 is a potent, selective, and orally available BET/BRD4 bromodomain inhibitor; disrupts BRD4 with an IC50 of 1.7 nM.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-133821
CAS No.: 142234-85-3
Purity:  97.83%
N-Methylmesoporphyrin IX (NMM), a widely used G-quadruplex DNA specific fluorescent binder, is an efficient probe for monitoring Aβ fibrillation. N-Methylmesoporphyrin IX is an in situ inhibitor and an ex situ monitor for Aβ amyloidogenesis both in vitro and in cells. N-Methylmesoporphyrin IX is sensitive to G-quadruplexes DNA but has no response to duplexes, triplexes and single-stranded forms DNA. N-Methylmesoporphyrin IX is nonfluorescent alone or in monomeric Aβ environments, but emits strong fluorescence through stacking with the Aβ assemblies .
loading...
    loading...